Marcus Chapman's most recent trade in Seres Therapeutics Inc was a trade of 24,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 4, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Seres Therapeutics Inc | Marcus Chapman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
Seres Therapeutics Inc | Marcus Chapman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 12,000 | 12,000 | - | - | Restricted Stock Units | |
Seres Therapeutics Inc | Marcus Chapman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2020 | 18,596 | 18,596 | - | - | STOCK OPTION (RIGHT TO BUY) |